DizzinessHypoglycemiaHyperglycemiaVertigoBlood GlucoseInsulinVestibular DiseasesHypoglycemic AgentsDiabetes Mellitus, Type 1GlucagonGlucoseVestibular Function TestsVestibular NeuronitisHyperinsulinismDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Glucose Clamp TechniqueHemoglobin A, GlycosylatedEpinephrineBlood Glucose Self-MonitoringPancreatic PolypeptideInsulin Infusion SystemsMeniere DiseaseInsulin, Long-ActingDiabetes MellitusC-PeptideGlucose Tolerance TestStreptozocinNystagmus, PathologicInsulin ComaClinical AlarmsHeadacheIslets of LangerhansWhiplash InjuriesGluconeogenesisFastingTime FactorsVentromedial Hypothalamic NucleusTreatment OutcomeSulfonylurea CompoundsPostural BalanceNystagmus, PhysiologicNesidioblastosisPostprandial PeriodHydrocortisoneCongenital HyperinsulinismInsulinomaSensation DisordersInsulin-Secreting CellsSyncopePancreas, ArtificialGlipizideGlucokinaseInsulin ResistanceLabyrinth DiseasesDiabetes ComplicationsPregnancy in DiabeticsNorepinephrineRetrospective StudiesFatty Acids, NonesterifiedDiagnostic Techniques, OtologicalRisk FactorsHomeostasisDiabetic AngiopathiesDouble-Blind MethodDiabetic KetoacidosisDiazoxideGlucagon-Like Peptide 1Rats, Sprague-Dawley3-Hydroxybutyric AcidInsulin AntibodiesLiverCritical IllnessGlycosuriaInsulin LisproInsulin AspartInsulin, IsophanePancreasPhlorhizinDose-Response Relationship, DrugLabyrinthine FluidsInfusions, IntravenousProspective StudiesMetforminMonitoring, AmbulatoryPancreatectomyHypotension, OrthostaticInfusions, SubcutaneousDipeptidyl-Peptidase IV InhibitorsDrug Administration ScheduleReference ValuesAwarenessMotion SicknessBody WeightOtorhinolaryngologic DiseasesCaloric TestsHuman Growth HormoneLactic AcidGlucagon-Secreting CellsLactates